1 January 2018 in International Journal of Surgery Case Reports
Introduction: Hepatic artery aneurysms (HAA) are rare and life-threatening. Presentation of case: We report a case of a 68-year-old man with a huge HAA diagnosed incidentally. Computed tomography showed a huge HAA (67-84 mm diameter). The patient underwent aneurysm resection and ligation of the common and proper hepatic arteries via laparotomy. Revascularization was not performed because intraoperative ultrasound showed pulsatile inflow to the left hepatic lobe. Postoperative cholecystitis and hepatic infarction were temporarily observed. Two months after the previous discharge, cholecystectomy was performed. Discussion: A diameter ≥5 cm of HAA is thought to be rare in arterial aneurysm diseases. There is no consensus in the treatment policy and treatment is selected according to the patient's condition. In this case, we selected open surgery for this patient instead of endovascular surgery due to rupture risks, irregularity and narrowness of vessel structure, and prolonged irradiation-time. If revascularization is not performed at the time of resection, open surgery with cholecystectomy is capable of preventing postoperative cholangitis after resection of HAA, and should be taken into account even if collateral circulation can be confirmed. Conclusion: This case highlights the difficulty of managing HAA and provides insight into a successful surgical treatment of HAA without complete revascularization. Highlights:
1 January 2015 in Japanese Journal of Cardiovascular Surgery
症例は74歳男性,胸痛を主訴にショック状態で救急搬送された.心エコーで中等量の心嚢水を認め,造影CTで上行大動脈の壁肥厚と径拡大があり,解離は明らかではなかった.心嚢水はCT値から血性と考えられることより,Stanford A型急性大動脈解離,偽腔閉塞型を強く疑い,ただちに緊急手術を施行した.外観上,大動脈基部から上行大動脈にかけて外膜血腫を認め,大動脈切開部から内腔を観察すると右冠尖と左冠尖の交連部直上に8 mmの内膜亀裂を認めた.この部分に一致して外膜にピンホールの穿孔を認め,他に動脈解離所見がないことから特発性大動脈基部破裂と診断した.交連部直上の亀裂部を大動脈壁外側から直接縫合し,穿孔部の閉鎖と交連部の再固定を行った.さらに外膜血腫のある拡大した上行大動脈を人工血管置換した.術後経過は良好で,術後14日目でリハビリ転院した.
18 February 2025 in The Heart Surgery Forum
Background: Although sutureless aortic valve replacement is rising in popularity, there are few reports on its use in patients on dialysis. This study aimed to investigate the early and mid-term surgical outcomes of the procedure in these patients. Methods: Twenty-one dialysis (mean age, 77.4 ± 5.2 years) patients with aortic stenosis who underwent aortic valve replacement with sutureless and rapid deployment prostheses between May 2019 and March 2021 were enrolled. We retrospectively reviewed and analyzed the clinical courses of all dialysis patients. Data on patient characteristics, surgical procedures, and postoperative outcomes (survival times and major adverse cardiac and cerebrovascular events) were collected. The mean follow-up duration was 371 days (interquartile range (IQR) 364–399). Results: Two (9.5%) operative deaths occurred within 30 days of surgery. The 1-year survival was 85.7%, and the rates of freedom from cardiac death, myocardial infarction, and stroke were 95.0%, 89.7%, and 95.0%, respectively. 1 year freedom from major adverse cardiac and cerebrovascular events was 67.8%. There was one (5.5%) permanent pacemaker implantation 9 months after surgery. No reoperations were performed for any cause. Three patients had moderate prosthesis-patient mismatch 4–7 days after surgery. Effective orifice area index improved from 0.74 cm2/m2 to 0.87 cm2/m2 in one patient 1 year after surgery. No cases of structural valve deterioration or a paravalvular leak were observed. Conclusions: Sutureless aortic valve replacement in dialysis patients may be a novel treatment strategy with lower early mortality rates comparable to those of conventional treatments, increased freedom from pacemaker implantation, and good valve function.
17 April 2025 in The Heart Surgery Forum
Background: Sutureless valves are gaining interest for aortic valve replacement in patients with small annuli; however, their effectiveness compared to traditional valves remains unclear. This study aimed to explore the clinical outcomes and hemodynamic performance of sutureless versus stented valves. Methods: In total, 190 patients underwent aortic valve replacement (AVR) at two hospitals from May 2019 to March 2022; 60 patients underwent AVR with Perceval S sutureless aortic valves S size (P group), and 130 underwent AVR with INSPIRIS RESILIA 19 mm (I-19 group) or 21 mm valves (I-21 group). We retrospectively reviewed and analyzed the patient characteristics and intra- and postoperative outcomes. Results: The mean cardiopulmonary bypass (CPB) and aortic cross-clamp (ACC) times were significantly shorter in the P group than in the I group. There were no significant differences in intensive care unit length of stay, hospitalization, and 30-day mortality. The echocardiographic evaluation showed no significant differences in prosthesis performances between the P group and I-19 group 4–7 days after surgery. However, the performance in the I-21 group significantly differed from that in the P group. At the 1 year follow-up, prosthesis performance in the P group was equivalent to that in the I-21 group. Conclusions: Surgical intervention with S size Perceval S sutureless valves is a safe and effective treatment for patients with a small aortic annulus and demonstrates superior intermediate-term hemodynamic performance.
29 December 2025 in Journal of Cardiothoracic Surgery
The frozen elephant trunk (FET) technique during total arch replacement (TAR) in patients with acute type A aortic dissection (ATAAD) has been shown to pro